`
Monday, 26 June 2017

Japan News

  • Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst

    Japan |  Analysis | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

    Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, representing a moderate compound annual growth rate (CAGR) of 4.6 pe...Read more

  • Teijin, Pulmagen enter agreement for asthma drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012

    Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeutics, a UK-based drug development company, have signed an exclusive l...Read more

  • Australian Cellmid acquires Japanese Advangen

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 09 May, 2013

    Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product range, which was orig...Read more

  • Belgium 3D printing firm forays into Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

    Materialise NV, a Belgium-based provider of 3D software and sophisticated 3D printing solutions, and a pioneer in medical image-based guided technology, has signed a 5-year partnership agre...Read more

  • Japan's Mitsubishi Tanabe pharma to revamp operations

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

    Singapore: With a view to streamline operations and speed up new drug launches, Japan's Mitsubishi Tanabe pharma recently announced plans to revamp and reorganize its three drug development...Read more

  • NTT's conductive fiber to help in biomedical recordings

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013

    Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating the surface of silk or synthetic fiber with conductive polymer (PEDO...Read more

  • Daiichi, ArQule enroll patient for cancer trial

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013

    Singapore: Daiichi Sankyo and ArQule announced that the first patient has been enrolled in the pivotal phase III METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (A...Read more

  • Three major Japanese labs collaborate on Parkinson's disease research

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2015

    Tokyo: Sumitomo Dainippon Pharma Co. Ltd., Center for iPS Cell Research and Application, Kyoto University (CiRA) and Hitachi Ltd. have signed a collaborative research program based on induc...Read more

  • BIO joins coalition to caution against further restructuring of Japan's Pharmaceutical Pricing

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

    Biotechnology Industry Organization (BIO) has made an announcement that the organization has joined a coalition of organizations urging the Government of Japan to maintain the established r...Read more

  • Japanese researchers discover potential drug target for muscle disease

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2015

    Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers have designed a model that reprograms fibroblasts to the early stage...Read more

  • Biocon, Fujifilm launch Insulin Glargine in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2016

    Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of receiving approval for its IQsulin Glargine from the Japanese regula...Read more

  • Takeda USA joins National Pharmaceutical Council

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2015

    Tokyo: The National Pharmaceutical Council (NPC) has inducted Takeda Pharmaceuticals USA Inc. (Takeda), a wholly-owned subsidiary of Japanese pharmaceutical major Takeda Pharmaceutical Comp...Read more

  • No more needles, no more pain!

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015

    Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles. The new met...Read more

  • HUYA appoints Yoshiki Shimamura as VP for Japan Operations

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2015

    The international operation of Chinese pharmaceutical company, HUYA Bioscience International (HUYA) has expanded its Senior Management Team, with the appointment of Yoshiki Shimamura as Vic...Read more

  • Kowa, Chugai to market liver cancer drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015

    Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug peretinoin under which Kowa will acquire the marketing authorization, and...Read more

  • Daiichi Sankyo to develop Cell Therapy's Heartcel for Japanese market

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 May, 2016

    Daiichi Sankyo Company Limited has signed a license agreement with UK-based Cell Therapy Ltd for an exclusive license in Japan to develop and market Heartcel, a immune-modulatory progenitor...Read more

  • RaQualia, Interprotein to research on pain drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013

    Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus on drug discovery research for a specific protein-protein interactio...Read more

  • Japan accepts Pluristem's regenerative cells as safe

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2015

    Israel's Pluristem Therapeutics Inc. has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cleared the company's PLX-PAD cells for use in clinical trials in Japan...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls